• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在HIV-1 gp120的V1环中鉴定出一种N-连接聚糖,其影响抗V3抗体和可溶性CD4的中和作用。

Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4.

作者信息

Gram G J, Hemming A, Bolmstedt A, Jansson B, Olofsson S, Akerblom L, Nielsen J O, Hansen J E

机构信息

Laboratory for Infectious Diseases, Hvidovre Hospital, Denmark.

出版信息

Arch Virol. 1994;139(3-4):253-61. doi: 10.1007/BF01310789.

DOI:10.1007/BF01310789
PMID:7832633
Abstract

Glycosylation is necessary for HIV-1 gp120 to attain a functional conformation, and individual N-linked glycans of gp120 are important, but not essential, for replication of HIV-1 in cell culture. We have constructed a mutant HIV-1 infectious clone lacking a signal for N-linked glycosylation in the V1-loop of HIV-1 gp120. Lack of an N-linked glycan was verified by a mobility enhancement of mutant gp120 in SDS-gel electrophoresis. The mutated virus showed no differences in either gp120 content per infectious unit or infectivity, indicating that the N-linked glycan was neither essential nor affecting viral infectivity in cell culture. We found that the mutated virus lacking an N-linked glycan in the V1-loop of gp120 was more resistant to neutralization by monoclonal antibodies to the V3-loop and neutralization by soluble recombinant CD4 (sCD4). Both viruses were equally well neutralized by ConA and a conformation dependent human antibody IAM-2G12. This suggests that the N-linked glycan in the V1-loop modulates the three-dimensional conformation of gp120, without changing the overall functional integrity of the molecule.

摘要

糖基化对于HIV-1 gp120获得功能性构象是必需的,并且gp120的单个N-连接聚糖对于HIV-1在细胞培养中的复制很重要,但并非必不可少。我们构建了一个突变的HIV-1感染性克隆,该克隆在HIV-1 gp120的V1环中缺乏N-连接糖基化信号。通过SDS凝胶电泳中突变型gp120的迁移率增强来验证N-连接聚糖的缺失。突变病毒在每个感染单位的gp120含量或感染性方面均无差异,这表明N-连接聚糖在细胞培养中既不是必需的,也不影响病毒感染性。我们发现,在gp120的V1环中缺乏N-连接聚糖的突变病毒对V3环单克隆抗体的中和作用以及可溶性重组CD4(sCD4)的中和作用更具抗性。两种病毒均被伴刀豆球蛋白A和构象依赖性人抗体IAM-2G12同样有效地中和。这表明V1环中的N-连接聚糖可调节gp120的三维构象,而不会改变分子的整体功能完整性。

相似文献

1
Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4.在HIV-1 gp120的V1环中鉴定出一种N-连接聚糖,其影响抗V3抗体和可溶性CD4的中和作用。
Arch Virol. 1994;139(3-4):253-61. doi: 10.1007/BF01310789.
2
Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.V1区的N-连接寡糖对寡聚化人免疫缺陷病毒1型糖蛋白120 V3环中中和表位的保护作用。
AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1067-76. doi: 10.1089/088922201300343753.
3
Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies.人类免疫缺陷病毒1型gp120 C末端保守的N-连接寡糖与病毒对中和抗体的敏感性
Arch Virol. 1996;141(11):2139-51. doi: 10.1007/BF01718221.
4
A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.一种新型抗人免疫缺陷病毒1型gp120的人源抗体依赖于V1、V2和V3环,并有助于界定广泛中和抗体免疫球蛋白G1 b12的表位。
J Virol. 2003 Jun;77(12):6965-78. doi: 10.1128/jvi.77.12.6965-6978.2003.
5
Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.基于结构的HIV-1 gp120靶向去糖基化及其对中和敏感性和抗体识别的影响。
Virology. 2003 Sep 1;313(2):387-400. doi: 10.1016/s0042-6822(03)00294-0.
6
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.在CCR5限制性而非CXCR4利用型的原发性人类免疫缺陷病毒1型毒株的天然包膜糖蛋白寡聚体中,一个保守的、CD4诱导性V3环中和表位的隐秘性质。
J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005.
7
N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.V3环和gp120免疫沉默面的N-连接糖基化可保护1型人类免疫缺陷病毒SF162免受抗gp120和抗gp41抗体的中和作用。
J Virol. 2004 Apr;78(7):3279-95. doi: 10.1128/jvi.78.7.3279-3295.2004.
8
V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.HIV-1包膜蛋白V3环截短赋予对共受体抑制剂的抗性并增强对中和抗体的敏感性。
PLoS Pathog. 2007 Aug 24;3(8):e117. doi: 10.1371/journal.ppat.0030117.
9
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.能够呈现HIV-1 V3环冠部且构象适合产生447-52D样抗体的免疫原的设计。
Biochem J. 2006 Nov 1;399(3):483-91. doi: 10.1042/BJ20060588.
10
A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex.1型人类免疫缺陷病毒的全球中和抗性表型由介导包膜复合物感染性增强和构象变化的不同机制决定。
J Virol. 2000 May;74(9):4183-91. doi: 10.1128/jvi.74.9.4183-4191.2000.

引用本文的文献

1
Whole Genome Sequence Analysis of Porcine Astroviruses Reveals Novel Genetically Diverse Strains Circulating in East African Smallholder Pig Farms.猪星状病毒全基因组序列分析显示,东非小农户养猪场流行新型遗传多样化毒株。
Viruses. 2020 Nov 5;12(11):1262. doi: 10.3390/v12111262.
2
Overview of the Structure⁻Function Relationships of Mannose-Specific Lectins from Plants, Algae and Fungi.植物、藻类和真菌中甘露糖特异性凝集素的结构-功能关系概述。
Int J Mol Sci. 2019 Jan 10;20(2):254. doi: 10.3390/ijms20020254.
3
Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant.

本文引用的文献

1
Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.人类免疫缺陷病毒1型包膜糖蛋白gp120的V1/V2区域在原代巨噬细胞感染及可溶性CD4中和中的功能作用
J Virol. 1994 Apr;68(4):2253-9. doi: 10.1128/JVI.68.4.2253-2259.1994.
2
An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization.人类免疫缺陷病毒1型(HIV-1)糖蛋白120(gp120)V3环内的一个N-聚糖影响病毒中和作用。
Virology. 1994 Mar;199(2):431-8. doi: 10.1006/viro.1994.1141.
3
Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop.
通过免疫接种带有 VLP 制剂的抗体选择的包膜变体,引导针对 HIV-1 的体液反应朝向 MPER 相邻区域。
PLoS One. 2018 Dec 19;13(12):e0208345. doi: 10.1371/journal.pone.0208345. eCollection 2018.
4
The CD8-derived chemokine XCL1/lymphotactin is a conformation-dependent, broad-spectrum inhibitor of HIV-1.CD8 衍生趋化因子 XCL1/lymphotactin 是一种构象依赖性、广谱的 HIV-1 抑制剂。
PLoS Pathog. 2013;9(12):e1003852. doi: 10.1371/journal.ppat.1003852. Epub 2013 Dec 26.
5
Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1.利用结构生物学设计新型HIV-1包膜免疫原的最新进展。
Curr HIV Res. 2013 Sep;11(6):464-72. doi: 10.2174/1570162x113116660053.
6
Longitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodies.在未接受药物治疗的个体中对原发性 HIV-1 分离物进行的纵向研究显示出对抗 HIV-1 单克隆抗体敏感的变异体的出现。
PLoS One. 2011 Feb 23;6(2):e17253. doi: 10.1371/journal.pone.0017253.
7
Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection.从最近感染的、未经抗逆转录病毒治疗的印度患者不同时间点获得的对 b12 耐药的 HIV-1 克隆 C Env 克隆的自体中和和 CD4 依赖性的变化。
Retrovirology. 2010 Sep 22;7:76. doi: 10.1186/1742-4690-7-76.
8
The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions.原发性病毒的1型人类免疫缺陷病毒包膜刺突可抑制抗体进入可变区。
J Virol. 2009 Feb;83(4):1649-59. doi: 10.1128/JVI.02046-08. Epub 2008 Nov 26.
9
Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals.HIV-1 B亚型感染的初治个体中HIV-1包膜序列的中和模式及序列演变
AIDS Res Hum Retroviruses. 2008 Dec;24(12):1507-19. doi: 10.1089/aid.2008.0154.
10
Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies.猿猴免疫缺陷病毒gp41的糖基化掩盖了可成为中和抗体靶点的表位。
J Virol. 2008 Dec;82(24):12472-86. doi: 10.1128/JVI.01382-08. Epub 2008 Oct 1.
1型人类免疫缺陷病毒gp120表面糖蛋白的免疫化学分析:探究C4和V4结构域的结构以及C4结构域与V3环的相互作用
J Virol. 1993 Aug;67(8):4785-96. doi: 10.1128/JVI.67.8.4785-4796.1993.
4
Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.人T细胞白血病-淋巴瘤病毒(HTLV)在转化的人脐血淋巴细胞中的限制性表达。
Virology. 1983 Aug;129(1):51-64. doi: 10.1016/0042-6822(83)90395-1.
5
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.从艾滋病患者和艾滋病前期患者中检测、分离并持续生产细胞病变逆转录病毒(HTLV-III)。
Science. 1984 May 4;224(4648):497-500. doi: 10.1126/science.6200935.
6
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.HTLV-III/LAV在携带HTLV-I的细胞MT-2和MT-4中的感染及其在蚀斑试验中的应用。
Science. 1985 Aug 9;229(4713):563-6. doi: 10.1126/science.2992081.
7
Detection of HIV antigens in eluates from whole blood collected on filterpaper.检测滤纸采集的全血洗脱液中的HIV抗原。
Lancet. 1987 Mar 7;1(8532):566-7. doi: 10.1016/s0140-6736(87)90213-3.
8
A strategy simplifying site-directed mutagenesis in the CD4-binding region of HIV gp 120.一种简化HIV gp 120 CD4结合区域定点诱变的策略。
Arch Virol. 1989;107(3-4):301-5. doi: 10.1007/BF01317925.
9
An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1.一种用于检测针对不同HIV-1毒株包膜糖蛋白抗体的酶联免疫吸附测定法。
AIDS. 1989 Mar;3(3):155-63. doi: 10.1097/00002030-198903000-00006.
10
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.确定人类免疫缺陷病毒1型gp120糖蛋白中对与CD4受体相互作用至关重要的区域。
Cell. 1987 Sep 11;50(6):975-85. doi: 10.1016/0092-8674(87)90524-1.